CFO departure

Vicarious Surgical Inc. discloses CFO departure: Sarah Romano

Vicarious Surgical Inc. reported in a Form 8-K filed June 24, 2026 a change involving its Chief Financial Officer, Sarah Romano, effective July 22, 2026. The filing's own words are quoted below.

In the filing's words

On June 24, 2026, Sarah Romano notified the Board of Directors of her resignation as Chief Financial Officer of the Company, effective July 22, 2026, or such later date as may be mutually agreed upon by the Company and Ms. Romano.

Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.

CompanyVicarious Surgical Inc. (RBOT)
EventDeparture
OutgoingSarah Romano
EffectiveJuly 22, 2026
8-K filedJune 24, 2026
SEC CIK0001812173

Vicarious Surgical Inc. reported this change in a Form 8-K, Item 5.02, filed June 24, 2026. The filing's own words are quoted above.

Other records naming Sarah Romano

2

The outgoing officer on this record, matched by name. Career line.

2 months ago· 2026-08-26DepartureSSII

SS Innovations International, Inc. discloses CFO departure: Sarah Romano

2026-03-09 · 10-K signature

Sarah Romano signed Vicarious Surgical Inc.'s annual report as Chief Financial Officer (Principal Financial and Accounting Officer)

Also filed in June 2026

Other CFO moves on the record that month. All moves.

4 months ago· 2026-06-30TransitionBANX

ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell

4 months ago· 2026-06-30InterimIMNN

Imunon, Inc. names Josh Blacher interim CFO

4 months ago· 2026-06-30TransitionRANI

Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford

4 months ago· 2026-06-29InterimCVKD

Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO

4 months ago· 2026-06-29TransitionGCO

Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn

4 months ago· 2026-06-29TransitionTNYA

Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.

Sources

  • sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26

Something wrong about Sarah Romano? Send a correction with the primary source.